title: Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
authors.affiliation: Department of Neurology, University Hospital Bern and University of Bern, Inselspital, Freiburgstrasse 4, 3010 Bern, Switzerland. urs.fischer@insel.ch
authors.forename: Urs
authors.initials: U
authors.lastname: Fischer
authors.forename: Peter M
authors.initials: PM
authors.lastname: Rothwell
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology*; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D013777:Tetrazoles